Search for an ETF or holding
GridAI Technologies Corp. (GRDX) is an United Kingdom company in the healthcare sector, listed on NASDAQ. Market capitalization of 39 million USD (micro-cap).
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.